🟢 BioCryst Pharmaceuticals is trading 8.07% up in pre-market with no clear catalyst identified

BioCryst Pharmaceuticals is trading 8.07% higher in pre-market at $8.70, with no specific catalyst identified for the move.

• The price is compared with the October 14 close of $8.05.
• No fresh company-specific announcement explaining the October 15 move surfaced in the available search. The company’s latest listed release was its October 5 Scientific Advisory Board announcement.
• The broader market backdrop is weak and does not clearly explain the rise.